Encompass Health Corporation $EHC Stake Reduced by Family Firm Inc.

Family Firm Inc. trimmed its holdings in Encompass Health Corporation (NYSE:EHC) by 38.1% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 20,077 shares of the company’s stock after selling 12,357 shares during the quarter. Family Firm Inc.’s holdings in Encompass Health were worth $2,462,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in EHC. WPG Advisers LLC acquired a new stake in Encompass Health during the first quarter valued at approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in shares of Encompass Health by 749.0% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock valued at $42,000 after acquiring an additional 367 shares during the last quarter. Parkside Financial Bank & Trust boosted its stake in shares of Encompass Health by 179.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 478 shares of the company’s stock worth $59,000 after acquiring an additional 307 shares in the last quarter. Park Place Capital Corp acquired a new stake in shares of Encompass Health during the second quarter worth $72,000. Finally, Caitong International Asset Management Co. Ltd raised its position in shares of Encompass Health by 19.0% during the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock worth $73,000 after purchasing an additional 115 shares during the period. 97.25% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, EVP Patrick William Tuer sold 1,020 shares of the firm’s stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the sale, the executive vice president directly owned 18,846 shares of the company’s stock, valued at $2,329,177.14. This trade represents a 5.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 2.00% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on EHC shares. Truist Financial lifted their price target on Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a research note on Thursday, August 14th. Raymond James Financial raised shares of Encompass Health to a “strong-buy” rating in a research report on Friday, October 31st. KeyCorp boosted their price target on shares of Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a report on Tuesday, September 16th. Bank of America raised their price objective on shares of Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. Finally, Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a research note on Wednesday, October 8th. Three research analysts have rated the stock with a Strong Buy rating and eight have issued a Buy rating to the stock. Based on data from MarketBeat, Encompass Health has an average rating of “Buy” and a consensus price target of $142.86.

Encompass Health Stock Performance

EHC stock opened at $114.32 on Friday. The firm has a 50 day simple moving average of $122.88 and a 200 day simple moving average of $119.68. Encompass Health Corporation has a 52 week low of $87.85 and a 52 week high of $127.99. The stock has a market cap of $11.50 billion, a P/E ratio of 21.61, a P/E/G ratio of 2.20 and a beta of 0.91. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06.

Encompass Health (NYSE:EHC) last released its earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. The company had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Research analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a $0.19 dividend. The ex-dividend date is Friday, January 2nd. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. Encompass Health’s payout ratio is 14.37%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.